In non-small cell lung cancer (NSCLC), the MET-associated molecular mechanisms that drive tumorigenesis are c-Met protein overexpression (OE), MET amplification, and splice-site mutations leading to MET exon 14 skipping mutations. The gene discussed is MET; the disease is non-small cell lung carcinoma.